Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications, such ...

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal failure, characterised by progressive cyst formation that distorts renal architecture and ...

The best option for patients with end-stage renal disease is kidney transplantation. Increased demand for organs has driven the rise in living donor nephrectomy procedures, in which it is important ...

Kidney removal, medically known as a nephrectomy, is a major surgical procedure performed to treat kidney disease, cancer, or to enable a healthy individual to donate a kidney. While the operation can ...

Two studies compare certain outcomes of robotic-assisted vs. laparoscopic surgery for kidney removal or rectal cancer. Two studies published by JAMA compare certain outcomes of robotic-assisted vs ...

Please provide your email address to receive an email when new articles are posted on . Robotic partial nephrectomy appeared associated with predominantly superior outcomes compared with open or ...

Partial nephrectomy has been the procedure of choice for patients with poor renal function, tumors in solitary kidneys or bilateral renal tumors. The efficacy of partial nephrectomy in regard to ...

WASHINGTON, D.C. (May 15, 2011)––New techniques in science and technology allow the medical community to continually improve patient care and experience, but as these new procedures are introduced, ...

Another trial, Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME), has compared upfront cytoreductive nephrectomy prior to targeted ...

In patients with clinical stage 1 (cT1) renal masses, many physicians opt for nephron-sparing surgery, such as partial nephrectomy (PN) versus radical nephrectomy (RN). Both procedures have been shown ...

PN and RFA offer similar survival for cT1a RCC tumors ≤2 cm, but PN is superior for larger tumors. RFA may be considered for elderly patients with comorbidities, especially for tumors ≤2 cm. PN ...